0001213900-26-042976
SEC filingiSpecimen Inc. has repeatedly adjourned its 2025 Annual Meeting of Stockholders due to failure to achieve quorum, with the next reconvening scheduled for May 8, 2026; the record date and proposals remain unchanged from the November 21, 2025 Proxy Statement.
The repeated adjournments of iSpecimen Inc.'s 2025 Annual Meeting reflect an ongoing inability to secure a quorum — a procedural threshold required under Delaware law and the Company’s bylaws to hold valid shareholder votes. Five consecutive attempts (December 31, 2025 through April 10, 2026) failed to attract sufficient voting participation, suggesting low engagement among stockholders or logistical barriers to voting. While the Company has preserved the original proposals and record date, persistent adjournments delay governance actions such as director elections, auditor ratification, and advisory votes on executive compensation — all of which remain pending. This situation may raise concerns about shareholder responsiveness, board accountability, or underlying investor sentiment, though no adverse outcomes (e.g., contested proposals or withheld votes) are disclosed. The May 8, 2026 reconvening represents the latest effort to finalize the annual agenda; continued failure could trigger further disclosures or require alternative outreach measures.